Home・Elenco Azioni・Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings Inc (Class A)

Chiusa

SettoreSettore sanitario

6.52 -3.41

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

6.51

Massimo

6.57

Metriche Chiave
By Trading Economics
Entrata	-21M -24M
Vendite	-14M 51M
EPS	-0.07
Margine di Profitto	-47.189
Dipendenti	415
EBITDA	-17M -5.2M

Dividendi
By Acuity
Utili prossimi	5 nov 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	343M 2.7B
Apertura precedente	9.93
Chiusura precedente	6.52

Notizie sul Sentiment di mercato

By Acuity

100%

322 / 339 Classifica in Healthcare

Maravai LifeSciences Holdings Inc (Class A) Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 set 2026, 20:08 UTC

Maravai LifeSciences Holdings Inc is trading lower today, continuing a decline seen over the past six sessions amid broader market weakness.

10 set 2026, 23:11 UTC

Maravai LifeSciences Holdings Inc shares are lower in after-market trading, continuing a trend of declines with no specific news to explain the movement.

9 set 2026, 20:07 UTC

News

Maravai LifeSciences Holdings Inc shares declined, closing at their lowest point of the day after UBS raised its price target to $8.

4 set 2026, 19:16 UTC

Maravai LifeSciences Holdings Inc is trading higher during Friday's session, recovering from an early decline and remaining above its 20-day moving average. No specific news identified.

3 set 2026, 19:46 UTC

Maravai LifeSciences Holdings Inc is trading lower today, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

1 set 2026, 20:01 UTC

Maravai LifeSciences Holdings Inc is lower today, marking five consecutive sessions of declines amid rising oil prices and inflation concerns affecting market sentiment.

31 ago 2026, 20:07 UTC

Maravai LifeSciences Holdings Inc is lower today, marking five consecutive days of declines amid concerns over inflation and interest rate hikes from the Jackson Hole symposium.

28 ago 2026, 20:01 UTC

Shares of Maravai LifeSciences Holdings Inc are trading lower today, breaking a trend of higher closes amid rising U.S. Treasury yields and inflation concerns.

27 ago 2026, 20:01 UTC

Maravai LifeSciences Holdings Inc is trading lower, falling below its 20-day moving average amid no specific news to explain the decline.

26 ago 2026, 20:08 UTC

Maravai LifeSciences is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with no specific company news identified.

25 ago 2026, 20:07 UTC

Maravai LifeSciences is trading higher, supported by favorable market conditions amid declining oil prices and lower Treasury yields. Shares pulled back from earlier session highs.

24 ago 2026, 20:06 UTC

Maravai LifeSciences is declining amid broader market pressures from rising oil prices and geopolitical tensions, despite reaching a session high earlier.

21 ago 2026, 19:43 UTC

Maravai LifeSciences Holdings Inc is trading higher today, supported by increased investor interest and unusually high trading volume, despite no specific news identified.

20 ago 2026, 23:11 UTC

Maravai LifeSciences Holdings Inc. shares are trading roughly flat in after-market hours amid mixed market sentiment influenced by recent fluctuations in U.S. Treasury yields.

19 ago 2026, 23:11 UTC

Maravai LifeSciences Holdings Inc. shares are higher in after-market trading, recovering from an initial dip despite no specific news to explain the movement.

18 ago 2026, 19:56 UTC

Maravai LifeSciences is trading higher today, recovering from earlier lows, despite broader market pressures and rising Treasury yields amid inflation concerns.

17 ago 2026, 20:06 UTC

Maravai LifeSciences Holdings Inc is lower today, continuing a decline since Friday. Shares are near the lower end of their one-month range.

14 ago 2026, 19:16 UTC

Maravai LifeSciences Holdings Inc. shares are lower, retracing from earlier gains amid broader market concerns over a decline in U.S. retail sales.

11 ago 2026, 20:01 UTC

Maravai LifeSciences Holdings Inc. shares are lower today, continuing a trend of five consecutive daily declines and trading below the 20-day moving average.

10 ago 2026, 19:46 UTC

News

Maravai LifeSciences reported second-quarter revenue of $51.4 million, but shares are trading lower amid mixed analyst ratings and a continuing decline since Friday.

7 ago 2026, 20:02 UTC

News

Maravai LifeSciences shares are lower despite Wells Fargo raising the price target to $6.50 following a revenue increase to $51.4 million in Q2.

6 ago 2026, 23:51 UTC

News

Maravai LifeSciences reported second-quarter revenue of $51.4 million, exceeding expectations, but shares are lower in after-market trading amid a cautious full-year outlook.

3 ago 2026, 19:46 UTC

Maravai LifeSciences Holdings Inc shares are lower during Monday's session, trading below their 20-day moving average with no specific news to explain the decline.

31 lug 2026, 19:36 UTC

Maravai LifeSciences Holdings Inc. shares are lower today amid broader market volatility, having previously dropped to a session low before partially recovering.

30 lug 2026, 16:56 UTC

Maravai LifeSciences Holdings Inc shares are gaining amid broader market recovery, with the S&P 500 advancing as investors engage in bargain hunting.

29 lug 2026, 20:09 UTC

Maravai LifeSciences Holdings Inc shares declined during Wednesday's session, pulling back from earlier gains amid broader market volatility and rising oil prices.

28 lug 2026, 18:06 UTC

Maravai LifeSciences Holdings Inc is gaining during Tuesday's session, though it pulled back from earlier highs amid broader market pressure in the tech sector.

24 lug 2026, 19:36 UTC

Maravai LifeSciences Holdings Inc shares are lower amid broader market pressures, reflecting declines in the Nasdaq 100 following disappointing earnings from major tech companies.

23 lug 2026, 09:01 UTC

Maravai LifeSciences Holdings Inc. shares are lower in pre-market trading, continuing a decline since Wednesday's close without significant recovery.

22 lug 2026, 19:56 UTC

Maravai LifeSciences Holdings Inc. shares are lower today, retracing from earlier highs amid no specific company news. The stock remains above its 20-day moving average.

Confronto tra pari

Modifica del prezzo

Maravai LifeSciences Holdings Inc (Class A) Previsione

Consenso sulla valutazione

By TipRanks

Da acquistare moderatamente

4 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 4 che hanno fornito valutazioni azionarie a Maravai LifeSciences Holdings Inc (Class A) - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

322 / 339 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.